Hilar cholangiocarcinoma
MONDO:0003345A cholangiocarcinoma that arises from the junction, or adjacent to the junction, of the right and left hepatic ducts.
Also known as: Klatskin tumor, Klatskin's tumor, cholangiocarcinoma of hilar portion of hepatic duct, hilar CC, hilar CCA, hilar cholangiocarcinoma, hilar portion of hepatic duct cholangiocarcinoma, hilar cholangiocellular carcinoma
2993 clinical trials for this condition and its sub-types, 36 tagged with Hilar cholangiocarcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Bile duct cancer trial halted after just one patient
Disease control Stopped earlyThis phase II trial tested a combination of chemotherapy infused directly into the liver (HAIC) plus two immunotherapy drugs (atezolizumab and bevacizumab) given before and after surgery for high-risk bile duct cancer. The goal was to see if this approach could shrink tumors and …
Phase 2 • Sponsor: Peking University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Experimental bile duct cancer drug tested in tiny trial – already halted
Disease control Stopped earlyThis early-stage trial tested a new drug called NXP800 in 7 people with advanced bile duct cancer that had spread or stopped responding to treatment. The goal was to find a safe dose and see if the drug could shrink tumors by blocking a protein linked to cancer growth. However, t…
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC